Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC crossover trial for obstructive sleep apnoea
ACTRN12625000573459Phase 2Recruiting
- Sponsor
- Centre for Sleep Science, University of Western Australia
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dronabinol in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Centre for Sleep Science, University of Western Australia. Primary endpoints: Upper airway collapsibility, Upper airway muscle responsiveness and 1 more. Started Jun 2025; status: recruiting.
02
Drugs
dronabinol
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12625000573459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000573459.